What Is Pulmonary Infarction Symptoms Diagnosis Treatment?

A pulmonary infarction happens when blood flow to part of the lung is blocked long enough that the tissue dies. It is almost always caused by a pulmonary embolism — a clot that travels to the lungs — and it affects only a small percentage of people who have one. The symptoms are easy to miss because they overlap with pneumonia, pleurisy, and other lung problems. Diagnosis relies on imaging, and treatment centers on restoring blood flow and preventing new clots.

What Is Pulmonary Infarction Symptoms Diagnosis Treatment?

A pulmonary infarction is death of lung tissue caused by blocked blood supply. The lungs have a dual blood supply — the pulmonary arteries and the bronchial arteries — which is why most pulmonary embolisms do not cause infarction. The bronchial arteries often keep the tissue alive even when a pulmonary artery is blocked.

Infarction occurs when that backup supply fails, or when the blockage is large enough or the person has underlying heart or lung disease. Research consistently shows that infarction complicates a minority of pulmonary embolism cases. Estimates vary, but it is not the typical outcome.

The distinction matters. A pulmonary embolism is a blood flow problem. A pulmonary infarction is tissue death that results from it. You can have a significant embolism without infarction, and infarction almost never occurs without an embolism.

What Causes a Pulmonary Infarction?

The cause is a blockage in a pulmonary artery that lasts long enough to starve lung tissue of oxygen. In the vast majority of cases, that blockage is a blood clot that formed elsewhere — usually in the deep veins of the legs or pelvis — and traveled to the lungs. This is called a pulmonary embolism.

Less common causes exist. They include air embolism, fat embolism after a long bone fracture, amniotic fluid embolism during childbirth, and tumor cells blocking blood flow. These are rare compared to blood clots.

Certain conditions make infarction more likely when an embolism occurs:

• Heart failure, which reduces the bronchial artery backup supply
• Chronic lung disease such as COPD
• Larger clots that block more of the arterial tree
• Shock or low blood pressure

The relationship between embolism size and infarction is not straightforward. Some large embolisms cause no infarction, while smaller ones sometimes do. What matters is whether the tissue’s oxygen demand exceeds what the remaining blood supply can deliver.

What Are the Symptoms of Pulmonary Infarction?

The classic symptom triad is chest pain, coughing up blood, and shortness of breath. But not everyone has all three, and many people have only one or two. This is part of why diagnosis is difficult.

Chest pain from pulmonary infarction tends to be pleuritic — it gets worse when you breathe in deeply, cough, or sneeze. This happens because the infarct is often near the edge of the lung, where it irritates the pleura, the thin membrane surrounding the lung. The pain is usually sharp and localized rather than the dull, pressure-like pain of a heart attack.

Coughing up blood, called hemoptysis, occurs in some but not all cases. It happens when the dead tissue bleeds into the airways. The amount is usually small — streaks of blood in sputum rather than large volumes.

Other symptoms can include:

• Shortness of breath, which may be sudden or gradual
• Rapid heart rate
• Low-grade fever
• A feeling of anxiety or impending doom

These symptoms overlap heavily with pneumonia, pleurisy, and viral respiratory infections. A fever and cough with blood could easily be mistaken for pneumonia. That overlap is a major reason pulmonary infarction is sometimes missed on first evaluation.

Some people with pulmonary embolism — with or without infarction — have no symptoms at all. Others have symptoms of the underlying embolism, such as leg swelling or pain from a deep vein thrombosis, before any lung symptoms appear.

How Is Pulmonary Infarction Diagnosed?

Diagnosis starts with a clinical assessment. A doctor considers your symptoms, risk factors, and medical history. Risk factors for pulmonary embolism include recent surgery, prolonged immobility, active cancer, previous clots, pregnancy, and certain genetic clotting disorders.

No blood test can confirm pulmonary infarction directly. However, a D-dimer blood test can help rule out pulmonary embolism in people with low clinical probability. D-dimer is a breakdown product of blood clots. A normal result in a low-risk person makes embolism unlikely. An elevated result is nonspecific — it can rise from surgery, infection, pregnancy, and many other conditions.

Imaging is where the diagnosis is made:

• CT pulmonary angiography (CTPA) is the standard test. It uses contrast dye to show clots in the pulmonary arteries and can reveal the wedge-shaped areas of dead tissue typical of infarction.
• Chest X-ray may show a shadow in the lung, but it is often normal in pulmonary embolism. It is more useful for ruling out pneumonia and other causes.
• Ventilation-perfusion (V/Q) scan is sometimes used when CT contrast is not safe, such as in kidney disease or pregnancy.
• Pulmonary angiography is rarely used now but remains an option in certain cases.

On CT imaging, an infarct often appears as a wedge-shaped opacity with the wide end against the pleura. This pattern is characteristic but not unique to infarction — it can resemble other conditions.

An important point: the imaging findings of infarction and pneumonia can look similar. Doctors use the combination of symptoms, risk factors, and imaging patterns to tell them apart. Sometimes the distinction is only clear in retrospect.

How Is Pulmonary Infarction Treated?

Treatment targets the underlying cause — the clot — and supports the lungs while they recover. The mainstay is anticoagulation, medication that prevents existing clots from growing and new ones from forming. This allows the body’s own clot-dissolving systems to break down the blockage over time.

Common anticoagulants include heparin (given intravenously or by injection in the hospital), low-molecular-weight heparin, and oral medications such as warfarin or direct oral anticoagulants. The choice depends on the clinical situation, kidney function, bleeding risk, and whether the person is hospitalized.

For people with large or unstable pulmonary embolisms — those causing low blood pressure or heart strain — more aggressive treatment may be needed. This can include:

• Thrombolytic therapy — clot-dissolving drugs given through a vein or directly into the pulmonary artery
• Catheter-directed therapy — a procedure that delivers clot-dissolving medication or removes clot through a thin tube
• Surgical embolectomy — surgical removal of the clot, reserved for severe cases when other options fail or are not safe

Supportive care matters too. Oxygen is given if blood oxygen levels are low. Pain from pleurisy can be managed with analgesics. Most people with pulmonary infarction recover, but recovery takes time. The dead lung tissue does not grow back — it forms a small scar. Nearby healthy tissue takes over the work.

Long-term anticoagulation is usually continued for at least three months, and sometimes longer depending on the cause and the risk of recurrence. The duration is a decision made with your doctor based on your specific situation.

No clinical guidelines currently recommend specific diets, supplements, or lifestyle changes to treat pulmonary infarction itself. The focus is on anticoagulation and managing underlying conditions.

What Is the Outlook After Pulmonary Infarction?

Most people survive pulmonary infarction, especially when it is diagnosed and treated promptly. The dead tissue itself is not the main danger — the underlying embolism and its effects on the heart and lungs are.

The risk of death from pulmonary embolism varies widely. It is highest in people with low blood pressure, shock, or significant heart strain at the time of diagnosis. For those who are stable and treated, the outlook is generally good.

Some people develop long-term complications. Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare but serious condition where clots do not fully resolve and cause ongoing high blood pressure in the lung arteries. It can develop months or years after a pulmonary embolism. Symptoms include worsening shortness of breath and fatigue with activity. It is treatable, but diagnosis requires specific testing.

Recovery from the acute episode varies. Some people feel better within weeks. Others have lingering shortness of breath or reduced exercise tolerance for months. The extent of recovery depends on how much lung tissue was affected, your underlying health, and how quickly treatment started.

Can Pulmonary Infarction Be Prevented?

Prevention focuses on preventing the clots that cause it. If you are at risk for deep vein thrombosis or pulmonary embolism, there are steps that may help.

After surgery or during prolonged immobility, moving your legs and following your doctor’s instructions for mobility and compression devices can help. Some people are prescribed preventive anticoagulation after major surgery or during hospitalization. This is a decision your medical team makes based on your individual risk.

If you have had a clot before, your risk of another is higher. Long-term anticoagulation may be recommended. The decision depends on the cause of the first clot, your bleeding risk, and other health factors.

Recognizing the warning signs matters too. Sudden shortness of breath, chest pain that worsens with breathing, or coughing up blood should prompt urgent medical evaluation — especially if you have risk factors for clots. Early treatment can prevent a smaller embolism from becoming a larger one, and can reduce the chance of infarction.